Best Practice & Research Clinical Rheumatology
Volume 22, Issue 5 , Pages 897-911 , October 2008

The role of infectious agents in the pathogenesis of vasculitis

  • Nicolò Pipitone, MD, PHD (Dr.)
    • ,
  • Carlo Salvarani, MD (Dr.)

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Rheumatology, Arcispedale Santa Maria Nuova, Viale Risorgimento 80, 42100 Reggio Emilia, Italy. Tel.: +39 0522 296 684; Fax: +39 0522 295 836.

References 

  1. Scott DG, Watts RA. Classification and epidemiology of systemic vasculitis. British Journal of Rheumatology. 1994;33:897–899
  2. Mohan N, Kerr G. Infectious etiology of vasculitis: diagnosis and management. Current Rheumatology Reports. 2003;5:136–141
  3. Oldstone MB. Molecular mimicry and immune-mediated diseases. The FASEB Journal. 1998;12:1255–1265
  4. Rodriguez-Pla A, Stone JH. Vasculitis and systemic infections. Current Opinion in Rheumatology. 2006;18:39–47
  5. Dal Canto AJ, Virgin HW. Animal models of infection-mediated vasculitis. Current Opinion in Rheumatology. 1999;11:17–23
  6. Fong IW, Chiu B, Viira E, et al. Rabbit model for Chlamydia pneumoniae infection. Journal of Clinical Microbiology. 1997;35:48–52
  7. Esteban MJ, Font C, Hernandez-Rodriguez J, et al. Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients. Arthritis and Rheumatism. 2001;44:1387–1395
  8. Thibault S, Drolet R, Germain MC, et al. Cutaneous and systemic necrotizing vasculitis in swine. Veterinary Pathology. 1998;35:108–116
  9. Dangler CA, Baker SE, Kariuki NM, Chia SH. Murine cytomegalovirus-associated arteritis. Veterinary Pathology. 1995;32:127–133
  10. Berencsi K, Endresz V, Klurfeld D, et al. Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice. Cell Adhesion and Communication. 1998;5:39–47
  11. Persoons MC, Stals FS, dam Mieras MC, Bruggeman CA. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. The Journal of Pathology. 1998;184:103–109
  12. Golden MP, Hammer SM, Wanke CA, Albrecht MA. Cytomegalovirus vasculitis. Case reports and review of the literature. Medicine. 1994;73:246–255
  13. Presti RM, Pollock JL, Dal Canto AJ, et al. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. The Journal of Experimental Medicine. 1998;188:577–588
  14. Weck KE, Dal Canto AJ, Gould JD, et al. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nature Medicine. 1997;3:1346–1353
  15. Nicklin MJ, Hughes DE, Barton JL, et al. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. The Journal of Experimental Medicine. 2000;191:303–312
  16. Sohn S, Lee ES, Bang D, Lee S. Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. European Journal of Dermatology. 1998;8:21–23
  17. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;335:1078–1080
  18. Tinkle BT, Ngo L, Luciw PA, et al. Human immunodeficiency virus-associated vasculopathy in transgenic mice. Journal of Virology. 1997;71:4809–4814
  19. Terada LS, Gu Y, Flores SC. AIDS vasculopathy. The American Journal of the Medical Sciences. 2000;320:379–387
  20. Gherardi R, Belec L, Mhiri C, et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis and Rheumatism. 1993;36:1164–1174
  21. Malavolta Luiz Caetano, Bechara Milton Jacob. Infectious arteritis. Problems in General Surgery. 2001;18:88–91
  22. Frank MW, Mehlman DJ, Tsai F, et al. Syphilitic aortitis. Circulation. 1999;100:1582–1583
  23. Pagnoux C, Cohen P, Guillevin L. Vasculitides secondary to infections. Clinical and Experimental Rheumatology. 2006;24:S71–S81
  24. Tavora F, Burke A. Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu's and giant cell aortitis. Pathology. 2006;38:302–308
  25. Yokoi M, Kase M. Retinal vasculitis due to secondary syphilis. Japanese Journal of Ophthalmology. 2004;48:65–67
  26. Gaa J, Weidauer S, Sitzer M, et al. Cerebral vasculitis due to Treponema pallidum infection: MRI and MRA findings. European Radiology. 2004;14:746–747
  27. Gajaraj A, Victor S. Tuberculous aortoarteritis. Clinical Radiology. 1981;32:461–466
  28. O'Regan AW, Castro C, Lukehart SA, et al. Barking up the wrong tree? Use of polymerase chain reaction to diagnose syphilitic aortitis. Thorax. 2002;57:917–918
  29. Bacourt F, Goeau-Brissonniere O, Lacombe P, et al. Surgical treatment of a tuberculous thoracoabdominal aneurysm. Annals of Vascular Surgery. 1986;1:378–381
  30. Shah SM, Howard RS, Sarkies NJ, Graham EM. Tuberculosis presenting as retinal vasculitis. Journal of the Royal Society of Medicine. 1988;81:232–233
  31. Mahr A, Guillevin L, Poissonnet M, Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis and Rheumatism. 2004;51:92–99
  32. Guillevin L, Lhote F, Cohen P, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine. 1995;74:238–253
  33. Naouri M, Bacq Y, Machet MC, et al. Interferon-alpha and ribavirin treatment in a patient with hepatitis C virus-associated cutaneous periarteritis nodosa, Annales de Dermatologie et de Vénéréologie. 2006;133:679–682
  34. Lormeau C, Falgarone G, Roulot D, Boissier MC. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine. 2006;73:633–638
  35. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine. 2000;79:47–56
  36. Lamprecht P, Gause A, Gross WL. Cryoglobulinemic vasculitis. Arthritis and Rheumatism. 1999;42:2507–2516
  37. Roccatello D, Baldovino S, Rossi D, et al. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrology, Dialysis, Transplantation. 2004;19:3054–3061
  38. Chetty R. Vasculitides associated with HIV infection. Journal of Clinical Pathology. 2001;54:275–278
  39. Kaye BR. Rheumatologic manifestations of HIV infections. Clinical Reviews in Allergy & Immunology. 1996;14:385–416
  40. Font C, Miro O, Pedrol E, et al. Polyarteritis nodosa in human immunodeficiency virus infection: report of four cases and review of the literature. British Journal of Rheumatology. 1996;35:796–799
  41. Massari M, Salvarani C, Portioli I, et al. Polyarteritis nodosa and HIV infection: no evidence of a direct pathogenic role of HIV. Infection. 1996;24:159–161
  42. Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Human Pathology. 2000;31:374–379
  43. Roh SS, Gertner E. Digital necrosis in acquired immune deficiency syndrome vasculopathy treated with recombinant tissue plasminogen activator. The Journal of Rheumatology. 1997;24:2258–2261
  44. Calabrese LH, Estes M, Yen-Lieberman B, et al. Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis and Rheumatism. 1989;32:569–576
  45. Garcia-Garcia JA, Macias J, Castellanos V, et al. Necrotizing granulomatous vasculitis in advanced HIV infection. The Journal of Infection. 2003;47:333–335
  46. Gillams AR, Allen E, Hrieb K, et al. Cerebral infarction in patients with AIDS. AJNR. American Journal of Neuroradiology. 1997;18:1581–1585
  47. Calabrese LH, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Seminars in Arthritis and Rheumatism. 2005;35:166–174
  48. Reveille JD, Williams FM. Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. Best Practice & Research. Clinical Rheumatology. 2006;20:1159–1179
  49. Massabki PS, Accetturi C, Nishie IA, et al. Clinical implications of autoantibodies in HIV infection. AIDS (London, England). 1997;11:1845–1850
  50. Klaassen RJ, Goldschmeding R, Dolman KM, et al. Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clinical and Experimental Immunology. 1992;87:24–30
  51. Gisselbrecht M, Cohen P, Lortholary O, et al. Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases. Annales de Médecine Interne. 1998;149:398–405
  52. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Annals of Internal Medicine. 1995;123:192–194
  53. Ma-Krupa W, Jeon MS, Spoerl S, et al. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. The Journal of Experimental Medicine. 2004;199:173–183
  54. Rimenti G, Blasi F, Cosentini R, et al. Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen. The Journal of Rheumatology. 2000;27:2718–2720
  55. Wagner AD, Gerard HC, Fresemann T, et al. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis and Rheumatism. 2000;43:1543–1551
  56. Regan MJ, Wood BJ, Hsieh YH, et al. Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis and Rheumatism. 2002;46:1056–1060
  57. Helweg-Larsen J, Tarp B, Obel N, Baslund B. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford, England). 2002;41:445–449
  58. Mitchell BM, Font RL. Detection of varicella zoster virus DNA in some patients with giant cell arteritis. Investigative Ophthalmology & Visual Science. 2001;42:2572–2577
  59. Rodriguez-Pla A, Bosch-Gil JA, Echevarria-Mayo JE, et al. No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis. Journal of Clinical Virology. 2004;31:11–15
  60. Staud R, Corman LC. Association of parvovirus B19 infection with giant cell arteritis. Clinical Infectious Diseases. 1996;22:1123
  61. Gabriel SE, Espy M, Erdman DD, et al. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis and Rheumatism. 1999;42:1255–1258
  62. Salvarani C, Farnetti E, Casali B, et al. Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study. Arthritis and Rheumatism. 2002;46:3099–3101
  63. Aggarwal A, Chag M, Sinha N, Naik S. Takayasu's arteritis: role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. International Journal of Cardiology. 1996;55:49–55
  64. Popa ER, Stegeman CA, Kallenberg CG, Tervaert JW. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Research. 2002;4:77–79
  65. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. The New England Journal of Medicine. 1996;335:16–20
  66. Esper F, Shapiro ED, Weibel C, et al. Association between a novel human coronavirus and Kawasaki disease. The Journal of Infectious Diseases. 2005;191:499–502
  67. Cacoub P, Saadoun D, Limal N, et al. Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS (London, England). 2005;19(Suppl. 3):S128–S134
  68. Bilge I, Sadikoglu B, Emre S, et al. Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient. Pediatric Nephrology (Berlin, Germany). 2005;20:529–533
  69. Ovetchkine P, Brugieres P, Seradj A, et al. An 8-y-old boy with acute stroke and radiological signs of cerebral vasculitis after recent Mycoplasma pneumoniae infection. Scandinavian Journal of Infectious Diseases. 2002;34:307–309
  70. Heinrich A, Khaw AV, Ahrens N, et al. Cerebral vasculitis as the only manifestation of Borrelia burgdorferi infection in a 17-year-old patient with basal ganglia infarction. European Neurology. 2003;50:109–112
  71. Younger DS. Vasculitis of the nervous system. Current Opinion in Neurology. 2004;17:317–336
  72. Zouboulis CC, May T. Pathogenesis of Adamantiades-Behcet's disease. Medical Microbiology and Immunology (Berlin). 2003;192:149–155
  73. Mizushima Y, Matsuda T, Hoshi K, Ohno S. Induction of Behcet's disease symptoms after dental treatment and streptococcal antigen skin test. The Journal of Rheumatology. 1988;15:1029–1030
  74. Direskeneli H. Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51. Annals of the Rheumatic Diseases. 2001;60:996–1002
  75. Direskeneli H, Saruhan-Direskeneli G. The role of heat shock proteins in Behcet's disease. Clinical and Experimental Rheumatology. 2003;21:S44–S48
  76. Stanford M, Whittall T, Bergmeier LA, et al. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clinical and Experimental Immunology. 2004;137:201–208
  77. Jessop SJ. Cutaneous leucocytoclastic vasculitis: a clinical and aetiological study. British Journal of Rheumatology. 1995;34:942–945
  78. Naides SJ. Known causes of vasculitis in man. Cleveland Clinic Journal of Medicine. 2002;69(Suppl. 2):SII15–SII19
  79. Kanai K, Kuwabara S, Mori M, et al. Leukocytoclastic-vasculitic neuropathy associated with chronic Epstein-Barr virus infection. Muscle & Nerve. 2003;27:113–116
  80. Ban S, Goto Y, Kamada K, et al. Systemic granulomatous arteritis associated with Epstein-Barr virus infection. Virchows Archiv. 1999;434:249–254
  81. Murakami K, Ohsawa M, Hu SX, et al. Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Arthritis and Rheumatism. 1998;41:369–373
  82. Nakagawa A, Ito M, Iwaki T, et al. Chronic active Epstein-Barr virus infection with giant coronary aneurysms. American Journal of Clinical Pathology. 1996;105:733–736
  83. Dutz JP, Benoit L, Wang X, et al. Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood. 2001;97:95–100
  84. Sackier JM, Kelly SB, Clarke D, et al. Small bowel haemorrhage due to cytomegalovirus vasculitis. Gut. 1991;32:1419–1420
  85. Meyer MF, Hellmich B, Kotterba S, Schatz H. Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection?. Rheumatology International. 2000;20:35–38
  86. Merle H, Donnio A, Gonin C, et al. Retinal vasculitis caused by adult T-cell leukemia/lymphoma. Japanese Journal of Ophthalmology. 2005;49:41–45
  87. Marmor M, Hertzmark K, Thomas SM, et al. Resistance to HIV infection. Journal of Urban Health. 2006;83:5–17
  88. Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annual Review of Microbiology. 1994;48:585–617
  89. Patti JM, Bremell T, Krajewska-Pietrasik D, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infection and Immunity. 1994;62:152–161
  90. Zhou YF, Shou M, Guetta E, et al. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation. 1999;100:1569–1575
  91. Virgin HW. Immune regulation of viral infection and vice versa. Immunologic Research. 2005;32:293–315
  92. Steed A, Buch T, Waisman A, Virgin HW. Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. Journal of Virology. 2007;81:6134–6140
  93. Hoffman GS. Large-vessel vasculitis: unresolved issues. Arthritis and Rheumatism. 2003;48:2406–2414

PII: S1521-6942(08)00106-X

doi: 10.1016/j.berh.2008.09.009

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 5 , Pages 897-911 , October 2008

Article Tools